SEOUL (Reuters) - South Korea said on Monday it has been informed by Moderna of an unspecified production issue involving its COVID-19 vaccine, as the country expands its inoculation campaign for people aged 55-59 amid a fourth wave of infections.
It was not immediately clear what the production issue is, how much and long shipment will be impacted and whether other countries will be also affected by the problem.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!